Commercialization Planning for SBIR Awardees in 2026

Receiving an SBIR Phase I or Phase II award is a genuine milestone. It validates your technology, provides non-dilutive capital, and signals that a federal agency sees real merit in your work. But the award itself is not the finish line — it is the starting gate for a much harder challenge: turning a promising innovation into a sustainable business.

Commercialization planning is where many SBIR awardees stumble. The science gets done. The milestones get met. And then the funding runs out with no clear path to revenue, follow-on investment, or a customer willing to write a check. This guide is designed to help you avoid that outcome.

Why Commercialization Planning Cannot Wait Until Phase II

One of the most common mistakes SBIR recipients make is treating commercialization as a Phase II concern. In reality, reviewers at agencies like NIH, DOD, and DOE now scrutinize commercialization potential even at the Phase I stage. More importantly, the decisions you make during Phase I — which customer segments you talk to, what data you collect, how you frame the problem you are solving — directly shape whether your Phase II application is competitive and whether your technology has a market when the work is done.

Start customer discovery during Phase I, not after. Talk to at least 10 to 15 potential end users, procurement officers, or channel partners before your Phase I period of performance ends. The goal is not to sell anything. It is to understand whether the problem you are solving is actually painful enough that someone will pay to have it fixed.

Document these conversations. When you write your Phase II commercialization plan, specific quotes, named organizations, and concrete market signals are far more persuasive than generic market size statistics pulled from industry reports.

Building a Commercialization Plan That Reviewers and Investors Trust

A strong SBIR commercialization plan addresses four core questions: Who will buy this, why will they buy it, how will you reach them, and what will it cost to get there.

Agencies and investors alike are tired of commercialization sections that read like press releases. They want evidence-based reasoning. Here is how to structure a plan that holds up to scrutiny.

Define Your Primary and Secondary Customers

For most SBIR projects, there are at least two layers of customers. The federal agency funding your work may be the near-term customer, particularly for defense and intelligence-focused technologies. But sustainable commercialization usually requires a civilian commercial market as well.

Map out both. For your primary customer, describe the specific decision-maker who would authorize a purchase, the procurement process they use, and the budget cycle they operate on. For your secondary market, identify whether you are pursuing a direct sales model, a licensing arrangement, or a partnership with a larger prime contractor or commercial integrator.

Be honest about timelines. Federal procurement cycles are long. If your technology needs FAR Part 12 commercialization pathways or requires inclusion in a GSA schedule, plan for 18 to 36 months of lead time on top of your Phase II performance period.

Build a Credible Go-to-Market Strategy

Go-to-market strategy is where many small businesses default to vague language about partnerships and strategic alliances. Reviewers notice. Instead, name specific companies you have had conversations with. Reference letters of support, teaming agreements, or pilot program commitments if you have them.

For 2026, two go-to-market pathways are particularly worth considering. The first is the SBIR Phase III transition, where you pursue a direct contract with the funding agency or one of its contractors without additional competition. Many awardees overlook this pathway because it requires proactive engagement with the contracting office well before Phase II ends. Start those conversations at the 12-month mark of a 24-month Phase II.

The second pathway is dual-use commercialization, particularly relevant for technologies developed under DOD or DHS sponsorship. If your technology has civilian applications, document them explicitly and consider whether a spin-out commercial entity or licensing deal with an established company makes more sense than trying to scale a government contractor business into a commercial products company simultaneously.

Financial Projections That Tell a Real Story

Your commercialization plan needs financial projections, and they need to be defensible. Build a bottoms-up model rather than a top-down one. Instead of saying your technology addresses a 4 billion dollar market and you plan to capture 2 percent of it, show the specific contracts, licensing fees, or product sales that get you to a particular revenue number in years one through three post-award.

Include your funding gap analysis. SBIR funding rarely covers the full cost of commercialization. Identify explicitly how much additional capital you need, from what sources — whether that is SBIR Phase III contracts, venture capital, strategic investment, or non-dilutive grants from foundations or state programs — and what milestones you need to hit to access each source.

Leveraging Agency Resources and the SBIR Road Tour

Most agencies offer technical assistance programs specifically for SBIR awardees that go underutilized. NIH's Noblesse Oblige commercialization programs, the Air Force's AFWERX accelerator, and DOE's Lab-Embedded Entrepreneurship Program all provide access to mentors, market analysts, and potential partners at no additional cost to the awardee.

In 2026, several agencies have also expanded their use of SBIR transition assistance programs that connect Phase II awardees directly with large prime contractors. If your agency offers a matching program or a vendor day, attend it. These events create relationships that formal proposals cannot.

Managing the Phase II to Phase III Gap

The most dangerous period in an SBIR company's life is the window between Phase II completion and the first Phase III contract or commercial revenue. Cash runs out. Key technical staff leave. Momentum stalls.

Planning for this gap is not pessimistic — it is essential. Build a 12-month cash runway into your financial projections that extends beyond your expected Phase II end date. Pursue bridge funding through your state's SBIR matching grant programs, of which more than 25 states now operate active versions. Identify whether your technology is eligible for a USDA, EPA, or NSF supplemental award that could extend your runway while you close a Phase III deal.

If you are raising private capital, do it while the SBIR award is active and your technical risk is lower. Investors are more willing to engage when you have non-dilutive validation and a clear story about how their dollars complement federal funding rather than replace it.

Finding Your Next Funding Opportunity

Commercialization planning is an ongoing process, not a document you write once and file away. As your technology matures and your market understanding deepens, your funding strategy needs to evolve with it.

FundFly is built to help SBIR awardees and applicants navigate exactly this kind of complexity. The platform uses AI to match your company profile and technology focus to relevant SBIR solicitations, Phase III opportunities, foundation grants, and state-level funding programs across more than one million live opportunities. Instead of manually tracking agency solicitation calendars and missing deadlines, you get a personalized feed of funding opportunities that fit where your company is right now.

If you are an SBIR awardee planning your next move, or a small business just starting to explore federal funding, visit FundFly to see how AI-powered grant matching can sharpen your strategy and save you the hours that are better spent building your technology.